AI-generated summary
The authors systematically reviewed 17 randomized controlled trials of transcranial direct current stimulation (tDCS) and photobiomodulation (PBM) for cognition in Alzheimer's disease, published 2020 to 2024. They report that tDCS studies, mostly at 2 mA over the dorsolateral prefrontal cortex, supported efficacy and safety, while only three PBM studies were included and could not be combined. The authors conclude that both improved cognitive abilities despite heterogeneous measures and call for standardized metrics, especially for PBM.
- Studies included
- 17
- Who or what was studied
- Individuals with Alzheimer's disease
- Limits stated in the abstract
- The abstract notes heterogeneity of outcome measures, which prevented combined efficacy analysis, and that the PBM studies provided no safety evaluation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Due to the increasing global prevalence of Alzheimer's dementia (AD), neuromodulation techniques such as transcranial direct current stimulation (tDCS) and photobiomodulation (PBM) are considered potential complementary therapies.
Objective
We assessed the efficacy and safety of tDCS and PBM and their potential to enhance cognitive functions in individuals with AD.
Methods
This review primarily examined studies designed to evaluate the efficacy, followed by an assessment of the safety of tDCS and PBM for people with AD. The databases searched were PubMed, Scopus, and Web of Science Core Collection, resulting in 17 published randomized and controlled trials. References were screened over 5 years (2020-2024). The research design used PRISMA guidelines.
Results
Fourteen studies were considered for tDCS, and the current literature supports efficacy and safety at an amperage of 2 mA, with electrodes placed on the dorsolateral prefrontal cortex (DLPFC). Three studies were included for PBM. The heterogeneity of these study measures made them unsuitable for combined efficacy analysis, and they did not provide a safety evaluation.
Conclusions
Despite differences in efficacy assessments, tDCS and PBM improved cognitive abilities. There is an urgent need to standardize metrics for evaluating efficacy and safety, particularly for PBM. Future research is encouraged.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Transcranial direct current stimulation, Systematic review, Neuromodulation, Heterogeneity, Dementia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.